Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05323955 |
Title | Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib (BRIDGET) |
Acronym | BRIDGET |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Carey Anders, M.D. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Dana Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
University of Michigan Health System | RECRUITING | Ann Arbor | Michigan | 48109 | United States | Details |
Washington University in St. Louis | RECRUITING | Saint Louis | Missouri | 63130 | United States | Details |
Duke University Medical Center | RECRUITING | Durham | North Carolina | 27710 | United States | Details |
Ohio State University Comprehensive Cancer Center | RECRUITING | Columbus | Ohio | 43210 | United States | Details |
Providence Portland Medical Center | RECRUITING | Portland | Oregon | 97213 | United States | Details |
MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |